PharmaShots | Incisive News in 3 Shots

Subscribe Now

Active Lupus Nephritis

Aurinia Publishes the Results of Lupkynis (voclosporin) in P-III AURORA 1 Study for Patients with Active Lupus Nephritis in The Lancet

Aurinia Publishes the Results of Lupkynis (voclosporin) in P-III AURORA 1 Study for Patients with Active Lupus Nephritis in The La...

May 10, 2021

GSK's Benlysta (belimumab) Receives EC's Approval for the Treatment of Active Lupus Nephritis

GSK's Benlysta (belimumab) Receives EC's Approval for the Treatment of Active Lupus Nephritis

May 6, 2021

Aurinia Lupkynis (voclosporin) Receives US FDA's Approval to Treat Adult Patients with Active Lupus Nephritis

Aurinia Lupkynis (voclosporin) Receives US FDA's Approval to Treat Adult Patients with Active Lupus Nephritis

January 25, 2021

GSK Reports Results of Benlysta (belimumab- IV) in P-III BLISS-LN Study for Patients with Active Lupus Nephritis

GSK Reports Results of Benlysta (belimumab- IV) in P-III BLISS-LN Study for Patients with Active Lupus Nephritis

December 19, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us